At a glance
- Originator Johnson & Johnson
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Bronchodilators; Muscle relaxants; Vasodilators
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 31 Dec 1994 Preclinical development for Asthma in USA (Unknown route)